Skip to main content

Pathogen reduction treatment alters the immunomodulatory capacity of buffy coat-derived platelet concentrates.

Loh YS, Johnson L, Kwok M, Marks DC

Publication: Transfusion (2014) • Vol 54(3) • Page 577-84PMID: 23829895View on PubMed

Purpose

The purpose of this paper was to determine the effects of pathogen reduction treatment (PRT) on the interaction between platelets (Plt) and peripheral blood mononuclear cells (PBMNCs) in the presence or absence of lipopolysaccharide (LPS).

Conclusion

PRT-treatment had no effect on Plt count, volume, percentage viable or dead cells, or phosphatidylserine expression. The supernatant of PRT-treated Plts contained 2.5 fold, 1.8 fold and 1.8 fold higher concentrations of Regulated on Activation, Normal T cell Expressed and Secreted (RANTES), soluble P-selectin (sCD62P) and Plt factor 4 (PF4), respectively, regardless of the addition of LPS. PBMNCs alone secreted very low levels of RANTES, sCD62P, PF4, interleukin (IL)-8, tumor necrosis factor (TNF)-alpha, and IL-1beta, but IL-8, TNF-alpha, and IL-1beta levels increased significantly after stimulation with LPS. When control platelet concentrates (PCs) were stored 5 days or their supernatants were cocultured for 24 h with PBMNCs in the presence of LPS, the concentration of IL-8 was significantly lower and sCD62P was significantly higher than when PRT-treated PCs were stored 5 days and were cocultured with PBMNCs in the presence of LPS, but the effect on IL-8 was not found in the absence of LPS stimulation. Levels of RANTES and PF4 were higher after coculture with PC than in PBMNCs alone, but there was no affect of PRT-treatment. sCD64P, RANTES and PF4 were comparable in Plts alone and when PBMNCs were cocultured with the supernatants from Plts. Levels of IL-1beta and TNF-alpha were similar in PBMNCs after coculture with PCs or their supernatants and in PBMNCs alone. After coculture with PBMNCs in the presence of LPS, PRT-treated Plts had a lower percentage of Plts positive for CD62P expression compared to control-Plts, but this was not found in the absence of LPS.

Studies (1)

Purpose

The purpose of this study was to determine the effects of PRT on the interaction between Plts and PBMNCs in the presence or absence of LPS. PCs were obtained from pooled buffy-coats in the additive solution SSP+. After collection, PCs were split into two units, one of which was Mirasol treated (riboflavin and ultraviolet light) on day 1 while the other was saline treated. PBMNCs were obtained from a single buffy-coat and resuspended in Roswell Park Memorial Institute (RPMI) 1640.

Summary of Findings

PRT-treatment had no effect on Plt count, volume, percentage viable or dead cells, or phosphatidylserine expression. The supernatant of PRT-treated Plts contained 2.5 fold, 1.8 fold and 1.8 fold higher concentrations of RANTES, sCD62P and PF4, respectively, regardless of the addition of LPS (p<0.05, all). PBMNCs alone secreted very low levels of RANTES, sCD62P, PF4, IL-8, TNF-alpha, and IL-1beta, but IL-8, TNF-alpha, and IL-1beta levels increased significantly after stimulation with LPS (p=0.0313, all). When control PCs were stored 5 days or their supernatants were cocultured for 24 h with PBMNCs in the presence of LPS, the concentration of IL-8 was significantly lower and sCD62P was significantly higher than when PRT-treated PCs were stored 5 days and were cocultured with PBMNCs in the presence of LPS (p<0.0001, all), but the effect on IL-8 was not found in the absence of LPS stimulation. Levels of RANTES and PF4 were higher after coculture with PC than in PBMNCs alone, but there was no effect of PRT-treatment. sCD64P, RANTES and PF4 were comparable in Plts alone and when PBMNCs were cocultured with the supernatants from Plts. Levels of IL-1beta and TNF-alpha were similar in PBMNCs after coculture with PCs or their supernatants and in PBMNCs alone. After coculture with PBMNCs in the presence of LPS, PRT-treated specimens had a lower percentage of Plts positive for CD62P expression compared to control-Plts (p<0.05), but this was not found in the absence of LPS.

  • Biospecimens

    FluidBlood
    CellBlood
  • Preservation Types

    None (Fresh)
  • Diagnoses

    Normal
  • Platforms

    Cell count/volumeHematology/ auto analyzer
    Cell count/volumeFlow cytometry
    ProteinELISA
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen Aliquots and ComponentsBlood processing method
    Mirasol-treated
    Saline-treated
    StorageStorage conditions
    PRT-treated
    Saline-treated
    With LPS
    Without LPS
    StorageTime at room temperature
    1 day
    5 days